Profile
David McElligott is the founder of Ranar Therapeutics, Inc. He is currently the Chief Scientific Officer at Accelerator Services Corp since 2012.
Previously, he held the position of Senior Director-Drug Discovery at ICOS Corp.
from 1997 to 2011.
He also worked as a Principal at The Salk Institute for Biological Studies and as Vice President-Research & Development at Groove Biopharma Corp.
Additionally, he served as a Professor at The Scripps Research Institute.
From 2017 to 2021, he was the Chief Scientific Officer at Petra Pharma Corp.
He was also the President of Borealis Biotechnology LLC from 2007 to 2008.
Dr. McElligott completed his undergraduate and doctorate degrees at the University of Iowa.
David McElligott active positions
| Companies | Position | Start |
|---|---|---|
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Corporate Officer/Principal | 2012-02-29 |
Ranar Therapeutics, Inc.
Ranar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development on therapies | Founder | 2021-09-30 |
Former positions of David McElligott
| Companies | Position | End |
|---|---|---|
Petra Pharma Corp.
Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer diseases | Corporate Officer/Principal | 2021-10-29 |
Borealis Biotechnology LLC | President | 2008-08-29 |
The Salk Institute for Biological Studies
The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Corporate Officer/Principal | - |
Training of David McElligott
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Health Technology |
The Salk Institute for Biological Studies
The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Groove Biopharma Corp.
Groove Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Focuses on the generation of novel microRNA therapeutics | Commercial Services |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services invests in companies located in the United States. The firm focuses on the healthcare sector. It provides financing for early stage capital requirements. | Finance |
Petra Pharma Corp.
Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer diseases | Health Technology |
Borealis Biotechnology LLC | |
Ranar Therapeutics, Inc.
Ranar Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development on therapies | Commercial Services |
- Stock Market
- Insiders
- David McElligott
















